ketamine has been researched along with Hydrophobia in 9 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
Excerpt | Relevance | Reference |
---|---|---|
" He received therapeutic coma with intravenous diazepam and sodium thiopental to maintain an electroencephalographic burst suppression pattern, which was maintained for a period of 46 h, as well as intravenous ketamine (48 mg/kg/day) as a continuous infusion and ribavirin (48 to 128 mg/kg/day) via a nasogastric tube." | 7.73 | Failure of therapeutic coma and ketamine for therapy of human rabies. ( Desudchit, T; Hemachudha, T; Jackson, AC; Khawplod, P; Sittipunt, C; Suankratay, C; Sunsaneewitayakul, B; Wacharapluesadee, S; Wilde, H, 2006) |
" He received therapeutic coma with intravenous diazepam and sodium thiopental to maintain an electroencephalographic burst suppression pattern, which was maintained for a period of 46 h, as well as intravenous ketamine (48 mg/kg/day) as a continuous infusion and ribavirin (48 to 128 mg/kg/day) via a nasogastric tube." | 3.73 | Failure of therapeutic coma and ketamine for therapy of human rabies. ( Desudchit, T; Hemachudha, T; Jackson, AC; Khawplod, P; Sittipunt, C; Suankratay, C; Sunsaneewitayakul, B; Wacharapluesadee, S; Wilde, H, 2006) |
"Ketamine was one of the therapeutic agents used as a therapy for a human rabies survivor who did not receive rabies vaccine." | 1.35 | Human rabies therapy: lessons learned from experimental studies in mouse models. ( Jackson, AC; Owen, J; Rossiter, JP; Scott, CA; Weli, SC, 2008) |
"In this first report of rabies in Equatorial Guinea, problems accompanying the application of the Milwaukee Protocol are described." | 1.35 | Applying the Milwaukee protocol to treat canine rabies in Equatorial Guinea. ( David, D; Garcia, C; Guarda, DC; Rubin, J; Rupprecht, CE; Stamler, A; Willoughby, RE; Zohar, Z, 2009) |
"Treatment included induction of coma while a native immune response matured; rabies vaccine was not administered." | 1.33 | Survival after treatment of rabies with induction of coma. ( Amlie-Lefond, CM; Chusid, MJ; Ghanayem, NS; Hoffman, GM; Rupprecht, CE; Schwabe, MJ; Tieves, KS; Willoughby, RE, 2005) |
"The approach to management of the rabies normally should be palliative." | 1.32 | Management of rabies in humans. ( Bleck, TP; Dietzschold, B; Ertl, HC; Fu, ZF; Jackson, AC; Leach, RP; O'Reilly, M; Rupprecht, CE; Warrell, MJ; Wilde, H; Wunner, WH, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 9 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jackson, AC | 6 |
Scott, CA | 2 |
Owen, J | 1 |
Weli, SC | 2 |
Rossiter, JP | 1 |
Rubin, J | 1 |
David, D | 1 |
Willoughby, RE | 2 |
Rupprecht, CE | 3 |
Garcia, C | 1 |
Guarda, DC | 1 |
Zohar, Z | 1 |
Stamler, A | 1 |
van Thiel, PP | 1 |
de Bie, RM | 1 |
Eftimov, F | 1 |
Tepaske, R | 1 |
Zaaijer, HL | 1 |
van Doornum, GJ | 1 |
Schutten, M | 1 |
Osterhaus, AD | 1 |
Majoie, CB | 1 |
Aronica, E | 1 |
Fehlner-Gardiner, C | 1 |
Wandeler, AI | 1 |
Kager, PA | 1 |
Warrell, MJ | 1 |
Ertl, HC | 1 |
Dietzschold, B | 1 |
O'Reilly, M | 1 |
Leach, RP | 1 |
Fu, ZF | 1 |
Wunner, WH | 1 |
Bleck, TP | 1 |
Wilde, H | 2 |
Tieves, KS | 1 |
Hoffman, GM | 1 |
Ghanayem, NS | 1 |
Amlie-Lefond, CM | 1 |
Schwabe, MJ | 1 |
Chusid, MJ | 1 |
Ward, CA | 1 |
Hemachudha, T | 1 |
Sunsaneewitayakul, B | 1 |
Desudchit, T | 1 |
Suankratay, C | 1 |
Sittipunt, C | 1 |
Wacharapluesadee, S | 1 |
Khawplod, P | 1 |
9 other studies available for ketamine and Hydrophobia
Article | Year |
---|---|
Human rabies therapy: lessons learned from experimental studies in mouse models.
Topics: Animals; Apoptosis; Disease Models, Animal; Female; Humans; Ketamine; Mice; Mice, Inbred ICR; Minocy | 2008 |
Applying the Milwaukee protocol to treat canine rabies in Equatorial Guinea.
Topics: Amantadine; Anesthetics, Dissociative; Animals; Antiviral Agents; Child, Preschool; Combined Modalit | 2009 |
Fatal human rabies due to Duvenhage virus from a bat in Kenya: failure of treatment with coma-induction, ketamine, and antiviral drugs.
Topics: Adult; Animals; Antiviral Agents; Chiroptera; Coma; Fatal Outcome; Female; Humans; Kenya; Ketamine; | 2009 |
Therapy of rabies encephalitis.
Topics: Adolescent; Amantadine; Animals; Antibodies, Neutralizing; Antibodies, Viral; Antiviral Agents; Chir | 2009 |
Management of rabies in humans.
Topics: Adrenal Cortex Hormones; Animals; Antibodies, Monoclonal; Antibodies, Viral; Combined Modality Thera | 2003 |
Survival after treatment of rabies with induction of coma.
Topics: Adolescent; Amantadine; Anesthetics; Animals; Antiviral Agents; Athetosis; Benzodiazepines; Bites an | 2005 |
Recovery from rabies.
Topics: Amantadine; Anesthetics; Animals; Antiviral Agents; Bites and Stings; Chiroptera; Coma; Excitatory A | 2005 |
Rabies virus infection of primary neuronal cultures and adult mice: failure to demonstrate evidence of excitotoxicity.
Topics: Animals; Apoptosis; Caspase 3; Caspase Inhibitors; Cells, Cultured; Cysteine Proteinase Inhibitors; | 2006 |
Failure of therapeutic coma and ketamine for therapy of human rabies.
Topics: Adult; Animals; Brain; Coma; Disease Models, Animal; Excitatory Amino Acid Antagonists; Fatal Outcom | 2006 |